Coronavirus Outbreak Forces FDA To Suspend Inspections in China; Agency Will Use Other Monitoring Tools

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Coronavirus Outbreak Forces FDA To Suspend Inspections in China; Agency Will Use Other Monitoring Tools

Dennis Tosh

February 26, 2020 at 05:56 PM EST

Due to the coronavirus outbreak, the FDA has suspended its inspections of facilities in China that manufacture products regulated by the agency. Commissioner of Food and Drugs Dr. Stephen M. Hahn and Associate Commissioner for Regulatory Affairs Judith A. McMeekin said Feb. 24 that the FDA took the action in response to a Department of State travel advisory cautioning against... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Coronavirus Outbreak Forces FDA To Suspend Inspections in China; Agency Will Use Other Monitoring Tools

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT